Back to search

Article

Analysis of Patient Access to Orphan Drugs in Turkey

2020-10-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Rare diseases are life-threatening, serious, and chronic genetic conditions that require complex care and have a low prevalence. An estimated one in 15 people worldwide are affected by rare diseases. This study aims to analyze the accessibility, reimbursement status, licensed status, and Anatomical Therapeutic Chemical (ATC) codes of drugs that the European Medi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7b8051c1-8898-53a2-b8fc-499317df96a4
DOI
10.21203/rs.3.rs-93956/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Analysis of Patient Access to Orphan Drugs in TurkeyDOI 10.21203/rs.3.rs-93956/v1
Trend of clinical trials of new drugs for rare diseases in China in recent 10 yearsSemantic proximity
Initiatives to Promote Access to Medicines After the Publication of National Policy on Comprehensive Care of People With Rare Diseases in BrazilSemantic proximity
Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN networkSemantic proximity
Assessment of anticancer drug utilization pattern and patients’ survival—A single center experience from Saudi ArabiaSemantic proximity
Implementation status of pharmacological studies in the development of orphan drugsSemantic proximity
An opportunity for clinical pharmacology trained physicians to improve patient drug safety: A retrospective analysis of adverse drug reactions in teenagersSemantic proximity
Current Situation of Clinical Trials of Drugs for Children's Indications in ChinaSemantic proximity
Assessing the availability of Repurposed Orphan Drugs in IndiaSemantic proximity
Quantifying hope: An EU perspective of rare disease therapeutic space and market dynamicsSemantic proximity
Compassionate use of orphan drugsSemantic proximity
Access to Essential and Innovative Anti-cancer Medicines: A Longitudinal Study in Nanjing, ChinaSemantic proximity
U.S. Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018Semantic proximity
Select a neighboring publication to make it the new centre.